We are excited to introduce Cala kIQ Plus by Cala Health, a next-generation wearable designed to transform how essential tremor and Parkinson’s disease are treated. This wrist-worn neurostimulation device delivers personalized, non-invasive therapy that helps reduce hand tremors and improve daily motor function — bringing clinically validated treatment directly into everyday life.

Unlike traditional approaches that rely on medication or invasive procedures, Cala kIQ Plus uses adaptive transcutaneous nerve stimulation to target tremor symptoms in real time. The system continuously adjusts therapy modes to optimize relief based on individual response, enabling users to regain control during everyday tasks such as eating, writing, or holding objects.

Seamlessly integrated with a companion app, the wearable supports personalized calibration, therapy tracking, and data-driven adjustments over time. Whether at home or on the move, it provides precision, adaptability, and meaningful symptom relief without compromise.

About Cala Health

Cala Health is a bioelectronic medicine company focused on developing non-invasive wearable therapies for neurological conditions. By combining neuroscience, wearable sensors, and personalized stimulation algorithms, the company aims to provide effective, drug-free treatment options for patients with movement disorders.